Biocon Limited — Quarter and year ended March 31, 2026
| Sl. No. | Particulars | 3 months ended 31.03.2026 (Audited) (Refer Note 17) | 3 months ended 31.12.2025 (Unaudited) | 3 months ended 31.03.2025 (Audited) (Refer Note 17) | Year ended 31.03.2026 (Audited) | Previous Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income | |||||
| Revenue from operations | 6,047 | 6,213 | 6,438 | 23,464 | 22,426 | |
| Other income | 498 | 748 | 627 | 3,197 | 2,423 | |
| Total income | 6,545 | 6,961 | 7,065 | 26,661 | 24,849 | |
| 2 | Expenses | |||||
| a) Cost of materials consumed | 2,461 | 2,876 | 3,224 | 11,424 | 10,854 | |
| b) Purchases of stock-in-trade | – | – | – | 452 | – | |
| c) Changes in inventories of finished goods, work-in-progress and stock-in-trade | 295 | (155) | (60) | (1,187) | (546) | |
| d) Employee benefits expense | 936 | 1,217 | 1,243 | 4,672 | 5,013 | |
| e) Finance costs | 167 | 23 | 567 | 1,424 | 2,369 | |
| f) Depreciation and amortisation expense | 362 | 340 | 330 | 1,373 | 1,278 | |
| g) Other expenses | 1,562 | 1,542 | 1,428 | 5,848 | 5,478 | |
| Total | 5,783 | 5,843 | 6,732 | 24,006 | 24,446 | |
| Less: Recovery of cost from co-development partners (net) | – | – | (17) | (6) | (131) | |
| Total expenses | 5,783 | 5,843 | 6,715 | 24,000 | 24,315 | |
| 3 | Profit before tax and exceptional items (1-2) | 762 | 1,118 | 350 | 2,661 | 534 |
| 4 | Exceptional items (net) [refer note 16] | (188) | (1,963) | – | (2,151) | 6,075 |
| 5 | Profit/ (loss) before tax (3 + 4) | 574 | (845) | 350 | 510 | 6,609 |
| 6 | Tax expense [refer note 16] | |||||
| – Current tax charge/(credit) | (12) | 89 | 265 | 120 | 306 | |
| – Deferred tax charge/(credit) | 76 | (170) | (127) | 18 | 11 | |
| – Tax expense on removal of indexation benefit | – | – | – | – | 199 | |
| 7 | Net Profit/ (loss) for the period/ year (5-6) | 510 | (764) | 212 | 372 | 6,093 |
| 8 | Other comprehensive income/ (loss) | |||||
| A (i) Items that will not be reclassified to profit or loss | 69 | 6 | (48) | 48 | (19) | |
| (ii) Income tax relating to items that will not be reclassified to profit or loss | (12) | (1) | 20 | (3) | (26) | |
| B (i) Items that will be reclassified to profit or loss | (237) | (26) | (10) | (317) | (105) | |
| (ii) Income tax relating to items that will be reclassified to profit or loss | 59 | 7 | 2 | 80 | 26 | |
| Other comprehensive loss, net of taxes | (121) | (14) | (36) | (192) | (124) | |
| 9 | Total comprehensive income/ (loss) for the period/ year (7+8) | 389 | (778) | 176 | 180 | 5,969 |
| 10 | Paid-up equity share capital (Face value of Rs. 5 each) | 8,105 | 6,685 | 6,003 | 8,105 | 6,003 |
| 11 | Reserves i.e. Other equity | 2,62,693 | 1,09,241 | |||
| 12 | Earnings per share (Face value of Rs. 5 each) | |||||
| (a) Basic | (not annualised) 0.32 | (not annualised) (0.57) | (not annualised) 4.88 | (annualised) 0.27 | (annualised) 5.09 | |
| (b) Diluted | (not annualised) 0.32 | (not annualised) (0.57) | (not annualised) 4.87 | (annualised) 0.27 | (annualised) 5.09 |
| Particulars | As at March 31, 2026 (Audited) | As at March 31, 2025 (Audited) |
|---|---|---|
| A ASSETS | ||
| 1 Non-current assets | ||
| (a) Property, plant and equipment | 12,809 | 10,038 |
| (b) Capital work-in-progress | 5,232 | 6,867 |
| (c) Investment property | 500 | 540 |
| (d) Right-of-use asset | 396 | 415 |
| (e) Other intangible assets | 106 | 142 |
| (f) Intangible assets under development | 179 | 146 |
| (g) Financial assets | ||
| Investments | 2,48,056 | 1,13,826 |
| Other financial assets | 210 | 224 |
| (h) Income tax asset (net) | 1,699 | 1,433 |
| (i) Other non-current assets | 639 | 878 |
| Total non-current assets | 2,69,826 | 1,34,509 |
| 2 Current assets | ||
| (a) Inventories | 8,751 | 8,363 |
| (b) Financial assets | ||
| Investments | 1,721 | – |
| Trade receivables | 10,031 | 8,294 |
| Cash and cash equivalents | 914 | 2,495 |
| Other bank balances | 3 | 3 |
| Other financial assets | 454 | 1,347 |
| (c) Other current assets | 1,006 | 1,200 |
| Total current assets | 22,880 | 21,702 |
| TOTAL ASSETS | 2,92,706 | 1,56,211 |
| B EQUITY AND LIABILITIES | ||
| 1 Equity | ||
| (a) Equity share capital | 8,105 | 6,003 |
| (b) Other equity | 2,62,693 | 1,09,241 |
| Total Equity | 2,70,798 | 1,15,244 |
| 2 Non-current liabilities | ||
| (a) Financial liabilities | ||
| Borrowings | 935 | 22,515 |
| Lease liabilities | 7 | 24 |
| Other financial liabilities | 94 | 11 |
| (b) Provisions | 602 | 333 |
| (c) Deferred tax liability (net) | 69 | 136 |
| (d) Other non-current liabilities | 547 | 576 |
| Total non-current liabilities | 2,254 | 23,595 |
| 3 Current liabilities | ||
| (a) Financial liabilities | ||
| Borrowings | 10,568 | 6,195 |
| Lease liabilities | 23 | 25 |
| Trade payables | ||
| – Total outstanding dues of micro enterprises and small enterprises; and | 340 | 627 |
| – Total outstanding dues of creditors other than micro enterprises and small enterprises | 5,548 | 7,517 |
| Other financial liabilities | 1,370 | 1,340 |
| (b) Other current liabilities | 285 | 267 |
| (c) Provisions | 404 | 345 |
| (d) Current tax liabilities (net) | 1,116 | 1,056 |
| Total current liabilities | 19,654 | 17,372 |
| TOTAL EQUITY AND LIABILITIES | 2,92,706 | 1,56,211 |
| Year ended March 31, 2026 (Audited) | Year ended March 31, 2025 (Audited) | ||
|---|---|---|---|
| I | Cash flows from operating activities | ||
| Profit for the year | 372 | 6,093 | |
| | | Adjustments for: | ||
| Depreciation and amortisation expense | 1,373 | 1,278 | |
| Unrealised foreign exchange loss (net) | (107) | 10 | |
| Share based compensation expense | 218 | 400 | |
| Provision for/ (reversal of) doubtful debts, (net) | (1) | 57 | |
| Interest expense | 1,424 | 2,369 | |
| Interest income | (191) | (47) | |
| Net gain on financial instruments measured at fair value through profit or loss | (1,878) | (1,684) | |
| Net gain on derivative liability measured at fair value through profit or loss | (8) | (213) | |
| Loss on property, plant and equipment sold, (net) | – | 13 | |
| Net gain on sale of investments | (632) | (61) | |
| Dividend received | (264) | (302) | |
| Profit on sale of investment in subsidiary | – | (6,075) | |
| Exceptional items (non cash), (net) | 506 | – | |
| Preferential allotment expenses | 1,036 | – | |
| Tax expense | 138 | 516 | |
| Operating profit before changes in operating assets and liabilities | 1,986 | 2,354 | |
| Movement in operating assets and liabilities | |||
| Increase in inventories | (388) | (1,716) | |
| Decrease/(increase) in trade receivables | (1,566) | 2,108 | |
| Decrease in other assets | 392 | 309 | |
| Increase/(decrease) in trade payable, other liabilities and provisions | (2,011) | 3,582 | |
| Cash generated from / (used in) operations | (1,587) | 6,637 | |
| Income taxes paid (net of refunds) | (214) | (426) | |
| Net cash flow generated from/ (used in) operating activities | (1,801) | 6,211 | |
| II | Cash flows from investing activities | ||
| Purchase of property, plant and equipment (net) | (2,830) | (3,174) | |
| Purchase of other intangible assets | (55) | (46) | |
| Loan given to subsidiaries | (4,032) | (2,852) | |
| Purchase of current investments | (168,291) | (22,345) | |
| Proceeds from sale of current investments | 167,235 | 23,035 | |
| Purchase of equity shares of subsidiary | (36,197) | (5,550) | |
| Purchase of debentures of subsidiary | (21,715) | (11,900) | |
| Preferential allotment expenses | (1,036) | – | |
| Investments made in other companies | (52) | (25) | |
| Proceeds from sale of investments in subsidiary | – | 6,832 | |
| Investment in bank deposits and inter corporate deposits | (370) | (4,036) | |
| Redemption/maturity of bank deposits and inter corporate deposits | 1,182 | 9,419 | |
| Interest received | 80 | 450 | |
| Dividend received | 264 | 302 | |
| Net cash flow used in investing activities | (65,817) | (9,890) | |
| III | Cash flows from financing activities | ||
| Proceeds from issuance of share capital, (net) | 85,311 | – | |
| Repayment of long-term borrowings | (22,723) | – | |
| Purchase of treasury shares | (26) | – | |
| Proceeds from exercise of share options | 727 | 99 | |
| Proceeds from short-term borrowings, (net) | 3,715 | 5,580 | |
| Payment of lease liabilities | (24) | (23) | |
| Interest paid | (292) | (108) | |
| Dividend paid | (668) | (600) | |
| Net cash flow generated from financing activities | 66,020 | 4,948 | |
| IV | Net increase/ (decrease) in cash and cash equivalents (I + II + III) | (1,598) | 1,269 |
| V | Effect of exchange differences on cash and cash equivalents held in foreign currency | 17 | 3 |
| VI | Cash and cash equivalents at the beginning of the year | 2,495 | 1,223 |
| VII | Cash and cash equivalents at the end of the year (IV + V + VI) | 914 | 2,495 |
| Description | Year ended March 31, 2026 | Year ended March 31, 2025 |
|---|---|---|
| Cash and cash equivalents | ||
| Balances with banks – on current accounts | 909 | 2,490 |
| – on unpaid dividend accounts | 5 | 5 |
| Total | 914 | 2,495 |
| Sl. No. | Particulars | 3 months ended 31.03.2026 (Audited) (Refer Note 17) | 3 months ended 31.12.2025 (Unaudited) | 3 months ended 31.03.2025 (Audited) (Refer Note 17) | Year ended 31.03.2026 (Audited) | Previous year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|